ES450012A1 - Procedimiento de preparacion de nuevos derivados fenoxi y de sus sales de adicion con acidos minerales u organicos. - Google Patents

Procedimiento de preparacion de nuevos derivados fenoxi y de sus sales de adicion con acidos minerales u organicos.

Info

Publication number
ES450012A1
ES450012A1 ES450012A ES450012A ES450012A1 ES 450012 A1 ES450012 A1 ES 450012A1 ES 450012 A ES450012 A ES 450012A ES 450012 A ES450012 A ES 450012A ES 450012 A1 ES450012 A1 ES 450012A1
Authority
ES
Spain
Prior art keywords
piperazines
phenoxyphenyl
lower alkoxy
dimethylsulfamoyl
trifluoromethylthio
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired
Application number
ES450012A
Other languages
English (en)
Spanish (es)
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Science Union et Cie
Original Assignee
Science Union et Cie
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Science Union et Cie filed Critical Science Union et Cie
Publication of ES450012A1 publication Critical patent/ES450012A1/es
Expired legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D295/00—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms
    • C07D295/04—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms
    • C07D295/08—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms substituted by singly bound oxygen or sulfur atoms
    • C07D295/096—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms substituted by singly bound oxygen or sulfur atoms with the ring nitrogen atoms and the oxygen or sulfur atoms separated by carbocyclic rings or by carbon chains interrupted by carbocyclic rings
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/04—Anorexiants; Antiobesity agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/06—Antihyperlipidemics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D295/00—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms
    • C07D295/04—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms
    • C07D295/14—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms substituted by carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals
    • C07D295/155—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms substituted by carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals with the ring nitrogen atoms and the carbon atoms with three bonds to hetero atoms separated by carbocyclic rings or by carbon chains interrupted by carbocyclic rings

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Diabetes (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Obesity (AREA)
  • Hematology (AREA)
  • Child & Adolescent Psychology (AREA)
  • Urology & Nephrology (AREA)
  • Vascular Medicine (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Emergency Medicine (AREA)
  • Endocrinology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Agricultural Chemicals And Associated Chemicals (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
ES450012A 1975-07-21 1976-07-21 Procedimiento de preparacion de nuevos derivados fenoxi y de sus sales de adicion con acidos minerales u organicos. Expired ES450012A1 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GB30392/75A GB1489711A (en) 1975-07-21 1975-07-21 1-phenoxyphenyl-piperazine derivatives process for their preparation and pharmaceutical compositions containing the

Publications (1)

Publication Number Publication Date
ES450012A1 true ES450012A1 (es) 1977-07-16

Family

ID=10306953

Family Applications (1)

Application Number Title Priority Date Filing Date
ES450012A Expired ES450012A1 (es) 1975-07-21 1976-07-21 Procedimiento de preparacion de nuevos derivados fenoxi y de sus sales de adicion con acidos minerales u organicos.

Country Status (21)

Country Link
US (1) US4064245A (enExample)
JP (1) JPS5225783A (enExample)
AR (1) AR211273A1 (enExample)
AT (1) AT350576B (enExample)
AU (1) AU498329B2 (enExample)
BE (1) BE844343A (enExample)
CA (1) CA1085400A (enExample)
CH (1) CH595368A5 (enExample)
DE (1) DE2631885C2 (enExample)
ES (1) ES450012A1 (enExample)
FR (1) FR2318634A1 (enExample)
GB (1) GB1489711A (enExample)
GR (1) GR61593B (enExample)
IE (1) IE43258B1 (enExample)
MX (1) MX3413E (enExample)
NL (1) NL162075C (enExample)
OA (1) OA05385A (enExample)
PH (1) PH12743A (enExample)
PT (1) PT65380B (enExample)
YU (1) YU163075A (enExample)
ZA (1) ZA764305B (enExample)

Families Citing this family (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4210646A (en) * 1978-04-11 1980-07-01 Janssen Pharmaceutica N.V. Antimicrobial compositions containing 1-(aryloxyphenyl)piperazines
DE3235589A1 (de) * 1982-09-25 1984-03-29 Hoechst Ag, 6230 Frankfurt Benzylether von phenol-mannich-basen, verfahren zu ihrer herstellung, ihre verwendung sowie pharmazeutische praeparate auf basis dieser verbindungen, zwischenprodukte und verfahren zu deren herstellung
JPS63174868U (enExample) * 1987-04-14 1988-11-14
UA81749C2 (uk) 2001-10-04 2008-02-11 Х. Луннбек А/С Фенілпіперазинові похідні як інгібітори зворотного захоплення серотоніну
EP1968961A2 (en) 2005-12-21 2008-09-17 Decode Genetics EHF Biaryl nitrogen heterocycle inhibitors of lta4h for treating inflammation
TW200932233A (en) * 2007-11-13 2009-08-01 Lundbeck & Co As H Therapeutic uses of compounds having combined SERT, 5-HT3 and 5-HT1a activity
US10821106B2 (en) 2015-08-21 2020-11-03 Srx Cardio, Llc Composition and methods of use of novel phenylalanine small organic compounds to directly modulate PCSK9 protein activity
HK1260897A1 (zh) 2015-08-21 2019-12-27 Portola Pharmaceuticals, Inc. 使用四氢异喹啉小分子来结合并调节pcsk9的蛋白活性的组合物和方法
US10568882B2 (en) 2015-08-21 2020-02-25 Srx Cardio, Llc Phenylpiperazine proprotein convertase subtilisin/kexin type 9 (PCSK9) modulators and their use
WO2017147328A1 (en) 2016-02-23 2017-08-31 Portola Pharmaceuticals, Inc. Compounds for binding proprotein convertase subtilisin/kexin type 9 (pcsk9)
IL315313A (en) * 2018-08-24 2024-10-01 Xeniopro GmbH Aromatic molecules for use in the treatment of pathological conditions
US12115154B2 (en) 2020-12-16 2024-10-15 Srx Cardio, Llc Compounds for the modulation of proprotein convertase subtilisin/kexin type 9 (PCSK9)

Also Published As

Publication number Publication date
PT65380B (fr) 1978-01-19
IE43258B1 (en) 1981-01-14
US4064245A (en) 1977-12-20
ATA534376A (de) 1978-11-15
DE2631885C2 (de) 1982-07-15
FR2318634B1 (enExample) 1979-06-29
AU498329B2 (en) 1979-03-01
NL162075B (nl) 1979-11-15
IE43258L (en) 1977-01-21
GB1489711A (en) 1977-10-26
ZA764305B (en) 1977-07-27
PT65380A (fr) 1976-08-01
JPS5225783A (en) 1977-02-25
FR2318634A1 (fr) 1977-02-18
YU163075A (en) 1982-05-31
NL7608007A (nl) 1977-01-25
BE844343A (fr) 1977-01-20
CH595368A5 (enExample) 1978-02-15
AR211273A1 (es) 1977-11-15
GR61593B (en) 1978-12-02
AT350576B (de) 1978-06-15
AU1603976A (en) 1978-01-26
PH12743A (en) 1979-08-09
MX3413E (es) 1980-11-07
OA05385A (fr) 1981-02-28
NL162075C (nl) 1980-04-15
CA1085400A (fr) 1980-09-09
DE2631885A1 (de) 1977-02-10
JPS558504B2 (enExample) 1980-03-04

Similar Documents

Publication Publication Date Title
ES8206440A1 (es) Un procedimiento para la preparacion del enantiomero (-) de la n-metil-3-(2metilfenoxi)-3-fenilpropilamina.
ES8406429A1 (es) "un metodo de preparacion de nuevas sulfonamidas sustituidas" nota: se solicita como divisional de la patente de invencion n 516.504.
ES450012A1 (es) Procedimiento de preparacion de nuevos derivados fenoxi y de sus sales de adicion con acidos minerales u organicos.
ZM5980A1 (en) Heterocyclic compounds having fungicidal,herbicidal and plant-growth regulating properties
ZA83641B (en) A fungicidal indanylbenzamide
ES452727A1 (es) Procedimiento para preparar 1-(2-halogeno-2-fenil-etil)- -triazoles.
IE832254L (en) Fungicidal compounds
FR2415619A1 (fr) 3-chloro-2,6-dinitro-n-(phenyl substitue)-4-(trifluoromethyl) benzenamines fongicides
ES482949A1 (es) Un procedimiento para la preparacion de compuestos derivadosde piridoxina
IL67360A0 (en) Alpha-azolylglycols and their use as fungicides
SE8302824D0 (sv) New herbicidal compounds
FR2361335A1 (fr) 4-(3-(amino substitue)-2-hydroxypropoxy) - 5,6,7,8 - tetrahydro - 1,6,7 - naphtalenetriol
ES445960A1 (es) Procedimiento de preparacion de derivados fosforados.
ES8403882A1 (es) Un procedimiento para preparar esteres heterociclicos de acidos fenoxibenzoicos.
JPS5293771A (en) Benzotriazoles
FR2373524A1 (fr) N1-chloro-3,5-dinitrosulfanilamides herbicides et fongicides
AU545800B2 (en) New compounds
IL64067A0 (en) 2-(n-aryl,n-1,2,3-thiazolylcarbonyl)-aminobutyrolactones,their preparation and their use as fungicides
JPS52131537A (en) Tickcide and fungicide
ES8501409A1 (es) Procedimiento para la obtencion de oximeteres sustituidos
ES8103738A1 (es) Procedimiento para la preparacion de nuevas 3-hidroxi-1,4- benzodiazepin-2-onas
FR2396011A1 (fr) Nouvelles 2,3-dihydro-1,4-benzoxathines pour inhibition de lipogenese
GB1529253A (en) Phenylformamidines
JPS53111022A (en) Thiocarbamate and heribicides
ES8107003A1 (es) Procedimiento pra la preparacion de nuevas benzamidas susti-tuidas